Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shared Decision-Making Encounter Tool for Adjuvant Treatment of Lung Cancer: Randomized Control Trial

NCT06122064 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06122064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06122064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shared Decision-Making Encounter Tool for Adjuvant Treatment of Lung Cancer: Randomized Control Trial
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
November 20, 2023
Completion date
October 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung non-small cell carcinoma, stage ii lung cancer ajcc v8, stage iii lung cancer ajcc v8, stage iv lung cancer ajcc v8